Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Irinotecan is active against colorectal cancer in patients whose disease is refractory
to fluorouracil. We investigated the efficacy of these two agents combined for first-line
treatment of metastatic colorectal cancer.